期刊
JOURNAL OF CLINICAL MICROBIOLOGY
卷 54, 期 11, 页码 2647-2654出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.00698-16
关键词
-
类别
资金
- NorthShore University HealthSystem
Methicillin-resistant Staphylococcus aureus (MRSA) infection is a global health care problem. Large studies (e.g., > 25,000 patients) show that active surveillance testing (AST) followed by contact precautions for positive patients is an effective approach for MRSA disease control. With this approach, the clinical laboratory will be asked to select what AST method(s) to use and to provide data monitoring outcomes of the infection prevention interventions. This minireview summarizes evidence for MRSA disease control, reviews the involvement of the laboratory, and provides examples of how to undertake a program cost analysis. Health care organizations with total MRSA clinical infections of > 0.3/1,000 patient days or bloodstream infections of > 0.03/1,000 patient days should implement a MRSA control plan.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据